Heron Therapeutics Files Q1 2025 10-Q
Ticker: HRTX · Form: 10-Q · Filed: May 6, 2025 · CIK: 818033
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report, customer-concentration
Related Tickers: HRTX
TL;DR
HRTX Q1 2025 10-Q is in: Revenue & expenses detailed, RSU & AOCI updates.
AI Summary
Heron Therapeutics, Inc. (HRTX) filed its 10-Q for the period ending March 31, 2025. The company reported on its financial performance, including sales revenue and general and administrative expenses for the first quarter of 2025. The filing also details information regarding restricted stock units, accumulated other comprehensive income, and fair value measurements.
Why It Matters
This filing provides investors with an update on Heron Therapeutics' financial health and operational performance for the first quarter of 2025, impacting investment decisions.
Risk Assessment
Risk Level: medium — The filing contains information on customer concentration risk and financial performance, which can indicate potential business risks.
Key Numbers
- Q1 2025 — Reporting Period (First quarter of 2025 financial performance)
- 2025-03-31 — Balance Sheet Date (End of the reporting period)
Key Players & Entities
- HERON THERAPEUTICS, INC. (company) — Filer
- HRTX (company) — Ticker Symbol
- 20250331 (date) — Reporting Period End Date
- 20250506 (date) — Filing Date
- Hercules Capital Inc (company) — Mentioned in relation to a date
FAQ
What was Heron Therapeutics' net sales revenue for the first quarter of 2025?
The filing indicates 'us-gaap:SalesRevenueNetMember' for the period 2025-01-01 to 2025-03-31, but the specific dollar amount is not provided in this excerpt.
Does Heron Therapeutics face significant customer concentration risk?
Yes, the filing mentions 'us-gaap:CustomerConcentrationRiskMember' in relation to both 'us-gaap:SalesRevenueNetMember' and 'us-gaap:AccountsReceivableMember' for the period 2025-01-01 to 2025-03-31.
What is the company's fiscal year end?
Heron Therapeutics, Inc.'s fiscal year ends on 1231.
What were the General and Administrative Expenses for Q1 2025?
The filing references 'us-gaap:GeneralAndAdministrativeExpenseMember' for the period 2025-01-01 to 2025-03-31, but the specific dollar amount is not detailed in this excerpt.
Are there any details about restricted stock units (RSUs) in the filing?
Yes, the filing mentions 'us-gaap:RestrictedStockUnitsRSUMember' for the period 2025-01-01 to 2025-03-31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding HERON THERAPEUTICS, INC. /DE/ (HRTX).